Meng Ning | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Forensic Scientist

Dr. Meng Ning | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Chiba University | China

Dr. Meng Ning is an accomplished researcher at Chiba University, Japan, recognized for her pioneering work in the epigenetic regulation of cancer. She has made substantial contributions to understanding the non-catalytic roles of chromatin regulators, particularly in gastric cancer. Her expertise bridges molecular biology and clinical gastrointestinal oncology, enabling her to translate laboratory discoveries into potential therapeutic strategies. Meng Ning is known for her meticulous experimental design, innovative application of genome-editing technologies, and dedication to advancing cancer research through both independent studies and collaborative projects.

Professional Profile

ORCID

Education

Dr. Meng Ning completed her doctoral studies at Chiba University, Japan, where she focused on elucidating novel mechanisms of cancer progression. Her Ph.D. research revealed a previously unrecognized non-catalytic function of SETD1A in gastric cancer via the E2F4–TAF6 axis. Employing advanced techniques including transcriptomics, epigenomics, and genome-editing approaches, she was able to demonstrate this mechanism independently of traditional methyltransferase activity. Her academic training combines rigorous laboratory research with a strong foundation in clinical oncology, preparing her to conduct translational studies that link fundamental discoveries with therapeutic potential.

Experience

Dr. Meng Ning has extensive experience in both experimental and translational cancer research. She has collaborated with the Department of Pathology at the University of Tokyo to analyze clinical gastric cancer specimens, integrating molecular findings with patient data. Her work spans NGS-based studies, CRISPR genome editing, and multi-omics analyses, reflecting a versatile approach to cancer biology. Beyond laboratory research, she has contributed to the mentorship of junior researchers, participated in collaborative projects across institutions, and actively engaged in the scientific community through professional society memberships and research networks.

Research Interests

Dr. Meng Ning’s primary research interest lies in the epigenetic regulation of cancer, with a focus on non-catalytic functions of chromatin regulators. She investigates how these regulators influence tumor proliferation, cellular signaling, and transcriptional networks using advanced molecular biology techniques. Her research integrates next-generation sequencing, genome editing, and integrative bioinformatics to identify novel mechanisms underlying cancer progression. By connecting these molecular insights with clinical oncology, she aims to identify potential therapeutic targets and contribute to the development of innovative cancer treatments.

Awards

Dr. Meng Ning is nominated for the Best Researcher Award in recognition of her outstanding contributions to cancer epigenetics and translational oncology. Her research has introduced novel concepts in understanding chromatin regulator function and tumor biology, demonstrating originality, technical excellence, and significant impact in the field. Her dedication to advancing cancer research through rigorous experimentation and collaborative endeavors positions her as a leading researcher in her discipline.

Publications

Dr. Meng Ning has authored several high-impact, SCI-indexed publications as first or contributing author. Her work demonstrates innovative methodologies and deep insights into the molecular mechanisms of cancer:

Title: Non-catalytic role of SETD1A promotes gastric cancer cell proliferation through the E2F4–TAF6 axis in the cell cycle
Journal: Cell Death & Disease
Published on: 2025-08-23

Title: Non-enzymatic SETD1A activity drives breast cancer cell proliferation via cyclin K
Journal: Breast Cancer Research
Published on: 2025-08-11

Title: Integrated enhancer regulatory network by enhancer–promoter looping in gastric cancer
Journal: NAR Cancer
Published on: 2024-04-08

Conclusion

Dr. Meng Ning exemplifies excellence in scientific research through her innovative studies in cancer epigenetics and her commitment to translational application. Her work bridges basic molecular discoveries and clinical oncology, offering new avenues for therapeutic development. With a combination of technical skill, collaborative engagement, and visionary research, Meng Ning stands out as a highly deserving candidate for the Best Researcher Award. Her contributions not only advance the understanding of cancer biology but also inspire ongoing innovation in epigenetic and translational research.

Gulnar Ultanbekova | Agricultural and Biological Sciences | Best Researcher Award

Published on by Forensic Scientist

Assoc. Prof. Dr. Gulnar Ultanbekova | Agricultural and Biological Sciences | Best Researcher Award

Al-Farabi Kazakh National University | Kazakhstan

Dr. Gulnar Ultanbekova is an accomplished scientist and Acting Associate Professor of Biotechnology at Al-Farabi Kazakh National University. With more than two decades of dedicated service in microbiology and biotechnology, she has established herself as a leading figure in microbial research, applied agricultural biotechnology, and the development of innovative bioproducts. Her leadership at the Institute of Microbiology and Virology of Kazakhstan was instrumental in the creation of groundbreaking microbial preparations, including Rizovit-AKS and the antifungal drug Roseofungin-AS, both of which have been widely recognized for their scientific and practical impact. She has consistently demonstrated the ability to bridge fundamental research with real-world agricultural applications, earning her a reputation as a pioneer in microbial biotechnology and sustainable agriculture.

Professional Profile

Scopus

Google Scholar

ORCID

Education

Her academic journey began with a Bachelor’s degree in Biology, followed by a Master’s in Ecology, and culminating in a Doctorate in Biological Sciences from Al-Farabi Kazakh National University. This strong academic foundation provided her with expertise in microbial ecology, soil microbiology, and applied biotechnology. Over the years, she has complemented her formal education with continued professional development, mentorship under leading academicians, and hands-on research in microbial innovations. Her educational background has equipped her with the knowledge and skills necessary to address the challenges of soil fertility, crop productivity, and sustainable agricultural practices through microbial biotechnology.

Experience

Dr. Gulnar Ultanbekova professional career spans over twenty years in academic teaching, laboratory leadership, and applied research. She headed the Antibiotics Laboratory at the Institute of Microbiology and Virology of Kazakhstan, where she contributed to the development of novel antibiotics and microbial biofertilizers. In her role, she collaborated with agricultural enterprises to implement microbial technologies that improved soil fertility and crop yields in practical farming systems. She has authored several scientific books, guided numerous research projects, and supervised students in microbiology and biotechnology. Currently, as Acting Associate Professor at Al-Farabi Kazakh National University, she continues to balance teaching, mentorship, and high-impact research, ensuring the growth of both science and future scholars in her field.

Research Interest

Her primary research interests lie in microbial biotechnology, soil microbiology, plant-microbe interactions, and the design of microbial biofertilizers. She has specialized in exploring plant growth-promoting rhizobacteria, nitrogen-fixing actinobacteria, and antibiotic-producing microorganisms. Her work focuses on the development of multifunctional microbial preparations that restore soil fertility, enhance crop yield, and support sustainable agricultural systems. Through her projects, she has developed microbial strains with high infectivity and growth-stimulating activity, patented bio-organic fertilizers, and applied technologies that are now being implemented in real agricultural environments. Her research philosophy emphasizes sustainability, ecological balance, and the integration of advanced science with practical farming solutions.

Awards

Dr. Gulnar Ultanbekova has been recognized at the highest national level for her significant contributions to science and technology. She was honored with the State Prize of the Republic of Kazakhstan for her leadership in the development and commercialization of the antifungal drug Roseofungin-AS, a pioneering achievement in microbial biotechnology. Additionally, she has received the YEREN YENBEGI USHIN Medal from Al-Farabi Kazakh National University in recognition of her exceptional service, dedication to academic excellence, and contributions to institutional growth. These prestigious awards highlight both her scientific achievements and her role as a transformative figure in biotechnology.

Publications

Dr. Gulnar Ultanbekova has published more than fifty scientific papers in national and international journals. Her articles address themes such as soil fertility restoration through nitrogen-fixing actinobacteria, the role of microbial biofertilizers in enhancing legume productivity, and ecological approaches to crop improvement. Representative publications include:

Title: Antifungal activity against pathogens of cereals and characterization of antibiotics of Streptomyces sp. strain K-541 isolated from extreme ecosystems in Kazakhstan
Journal: Agricultural Biology
Published on: 2018
Citation: Cited by 7

Title: Isolation and selection of nodulating bacteria from the rhizosphere of legume (Vigna radiata) and bean (Phaseolus lunatus) plants and enhancement of specific properties
Journal: BIO Web of Conferences
Published on: 2024
Citation: Cited by 1

Title: Effect of UV irradiation of PGPR bacteria on seed germination and plant growth of mung bean (Vigna radiata)
Journal: European Science
Published on: 2019
Citation: Cited by 1

Title: Agrochemical compositions of soils and rhizosphere microorganisms of Rosa potentilliflora Chrshan. et M. Pop. in the eastern and central parts of the Zailiyskiy Alatau
Journal: Ecological Processes
Published on: 2025

Title: The use of predatory fungi of the genus Arthrobotrys isolated from soils of farmland in Southern Kazakhstan to control nematode infections in tomato plants
Journal: BIO Web of Conferences
Published on: 2024

Title: Influence of halophilic microorganisms Bacillus sp. PK-1 on the growth and development of maize under irrigated saline soil conditions in the Turkestan region
Journal: Eurasian Journal of Ecology
Published on: 2020

Title: Study on the effect of biopreparations based on streptomycete strains on wheat growth under conditions of Fusarium oxysporum infection
Journal: Biology and Medicine Series
Published on: 2017

Conclusion

Dr. Gulnar Ultanbekova is a highly accomplished researcher whose career exemplifies the integration of fundamental microbiology with applied biotechnology for agricultural sustainability. Through her research, she has introduced microbial solutions that improve soil fertility, crop productivity, and ecological balance. Her publications, patents, and books showcase a lifetime commitment to advancing science and technology, while her awards affirm the national recognition of her achievements. With a proven record of innovation, leadership, and impact, she stands as an exemplary candidate for the Best Researcher Award, embodying excellence in scientific research and dedication to societal advancement.

Narayana Nagesh | Biochemistry | Outstanding Scientist Award

Published on by Forensic Scientist

Prof. Narayana Nagesh | Biochemistry | Outstanding Scientist Award

Centre for Cellular and Molecular Biology, Hyderabad | India

Dr. Narayana Nagesh, Ph.D., FTAS, FRSC, is a distinguished Chief Scientist at the Centre for Cellular and Molecular Biology (CCMB), Hyderabad. With over three decades of experience in chemical biology, he has emerged as a pioneer in DNA chemistry, molecular diagnostics, and anticancer drug development. His career is marked by groundbreaking innovations in G-quadruplex DNA research and molecular probe development, alongside leadership in national scientific projects including COVID-19 testing and mRNA vaccine platforms.

Author Profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

Dr. Narayana Nagesh stands out as an exemplary candidate for the Outstanding Scientist Award due to his sustained, multidisciplinary contributions spanning over three decades at the Centre for Cellular and Molecular Biology (CCMB), Hyderabad. His research rigor and innovation are evident in his 94+ publications in high-impact journals, 2988+ citations, and an h-index of 35, reflecting both volume and influence.

His pioneering work on G-quadruplex DNA interactions, anticancer agents, mRNA vaccine platforms, and diagnostic biosensors underlines a career marked by scientific originality and societal relevance. Furthermore, his pivotal role during the COVID-19 pandemic—leading sample testing and mRNA vaccine platform development—demonstrates translational research leadership with direct public health impact. Dr. Nagesh has also contributed significantly to national capacity building, mentoring over 30 students, filing multiple patents, and leading interdisciplinary projects.

🎓 Education

Dr. Nagesh earned his Ph.D. in Chemistry (2002–2005), focusing on “Studies on the Structure and Interaction of G-Quadruplex DNA with Metal Ions and Drugs.” He completed post-doctoral research under Prof. Edwin A. Lewis at Northern Arizona University, USA (2006–2007), exploring Bcl2 Quadruplex DNA interactions. His strong academic foundation is complemented by merit recognitions during his M.Sc. and M.Phil. studies.

🧪 Experience

Joining CCMB as Scientist-B in 1990, Dr. Nagesh steadily rose to become Chief Scientist. He has led and collaborated on over eight major funded projects, generating ₹6.5 crores in extramural research funding. As a nodal project investigator, he has managed high-impact research on mRNA-based vaccines and diagnostics, and actively contributed to national-level scientific responses like COVID-19 testing.

🔬 Research Interests On Biochemistry

Dr. Nagesh’s expertise lies in medicinal chemistry, chemical biology, and molecular diagnostics. He specializes in G-quadruplex DNA interactions, synthesis of anticancer agents, aptamers, and targeted therapeutic molecules. His research extends into biophysical characterizations, ligand-DNA interactions, and small-molecule diagnostics for cardiovascular and infectious diseases. His interdisciplinary work bridges chemistry, biophysics, and disease biology.

🏅 Awards and Honors

Dr. Nagesh is a Fellow of the Telangana Academy of Sciences (2022) and a Fellow of the Royal Society of Chemistry (2024). He has received prestigious fellowships such as the NAU-TRIF and ABRC (USA), and the Indo-Swiss Joint Research Programme (ISJRP). His contributions to science have also earned him recognition in international academic committees, editorial boards, and funding panels.

📚 Selected Publications

  • Characterization of an alkaline active – thiol forming extracellular serine keratinase by the newly isolated Bacillus pumilus
    Authors: AG Kumar, S Swarnalatha, S Gayathri, N Nagesh, G Sekaran
    Year: 2008
    Citations: 144

  • DNA-binding affinity and anticancer activity of β-carboline–chalcone conjugates as potential DNA intercalators: Molecular modelling and synthesis
    Authors: N Shankaraiah, KP Siraj, S Nekkanti, V Srinivasulu, P Sharma, …
    Year: 2015
    Citations: 119

  • Design and synthesis of dithiocarbamate linked β-carboline derivatives: DNA topoisomerase II inhibition with DNA binding and apoptosis inducing ability
    Authors: A Kamal, M Sathish, VL Nayak, V Srinivasulu, B Kavitha, Y Tangella, …
    Year: 2015
    Citations: 107

  • Design and synthesis of C3-tethered 1,2,3-triazolo-β-carboline derivatives: Anticancer activity, DNA-binding ability, viscosity and molecular modeling studies
    Authors: AK Nagula Shankaraiah, Chetna Jadala, Shalini Nekkanti, Kishna Ram Senwar, …
    Year: 2016
    Citations: 101

  • Design and synthesis of C3‐pyrazole/chalcone‐linked beta‐carboline hybrids: antitopoisomerase I, DNA‐interactive, and apoptosis‐inducing anticancer agents
    Authors: A Kamal, V Srinivasulu, VL Nayak, M Sathish, N Shankaraiah, C Bagul, …
    Year: 2014
    Citations: 98

  • Production of melanin pigment from Pseudomonas stutzeri isolated from red seaweed Hypnea musciformis
    Authors: C Ganesh Kumar, N Sahu, G Narender Reddy, RBN Prasad, N Nagesh, …
    Year: 2013
    Citations: 91

  • Purification of extracellular acid protease and analysis of fermentation metabolites by Synergistes sp. utilizing proteinaceous solid waste from tanneries
    Authors: AG Kumar, N Nagesh, TG Prabhakar, G Sekaran
    Year: 2008
    Citations: 86

  • Genetic Locus Encoding Functions Involved in Biosynthesis and Outer Membrane Localization of Xanthomonadin in Xanthomonas oryzae pv. oryzae
    Authors: AK Goel, L Rajagopal, N Nagesh, RV Sonti
    Year: 2002
    Citations: 85

  • Synthesis of podophyllotoxin linked β-carboline congeners as potential anticancer agents and DNA topoisomerase II inhibitors
    Authors: AK Manda Sathish, Botla Kavitha, V. Laxma Nayak, Yellaiah Tangella, Ayyappan …
    Year: 2018
    Citations: 84

  • Copper Oxide Nanoparticles Supported on Graphene Oxide‐Catalyzed S‐Arylation: An Efficient and Ligand‐Free Synthesis of Aryl Sulfides
    Authors: A Kamal, V Srinivasulu, JC Murty, N Shankaraiah, N Nagesh, …
    Year: 2013
    Citations: 81

  • Synthesis of β-carboline–benzimidazole conjugates using lanthanum nitrate as a catalyst and their biological evaluation
    Authors: A Kamal, MPN Rao, P Swapna, V Srinivasulu, C Bagul, AB Shaik, …
    Year: 2014
    Citations: 76

  • Ammonium ion at low concentration stabilizes the G-quadruplex formation by telomeric sequence
    Authors: N Nagesh, D Chatterji
    Year: 1995
    Citations: 72

✅ Conclusion

Dr. Narayana Nagesh exemplifies scientific excellence with his pioneering work in DNA chemistry, diagnostics, and therapeutics. His contributions have influenced drug discovery, public health response (including COVID-19 testing), and molecular diagnostics across India. His commitment to innovation, societal impact, and mentorship of future scientists makes him an outstanding nominee for the Best Researcher Award under the Forensic Scientist Awards.